Vulvovaginal Candidiasis
📧 Sign up to get email alerts when something new happens for Vulvovaginal Candidiasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal Candidiasis [Phase 3]
Phase 3 clinical trial comparing SHR8008 to fluconazole for acute vulvovaginal candidiasis is underway.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303) [Phase 3]
Phase 3 trial assessing oral ibrexafungerp (SCY-078) versus placebo for acute vulvovaginal candidiasis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis [Phase 3]
Phase 3 trial evaluating oral ibrexnafungerp (SCY-078) versus placebo for acute vulvovaginal candidiasis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis [Phase 2]
Phase 2 dose-finding study comparing oral ibrexafungin (SCY-078) to fluconazole for acute vulvovaginal candidiasis has completed with posted…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis [Phase 4]
Phase 4 trial comparing fluconazole to medical honey for recurrent vulvovaginal candidiasis; status currently UNKNOWN.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis [Phase 4]
Phase 4 trial comparing terconazole vaginal suppository to fluconazole for severe vulvovaginal candidiasis completed with results posted.
-
FDA approval · 2020-07-22FDA Approved: MONISTAT 3 COMBINATION PACK 3 OVULE INSERTS — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application for Monistat 3 Combination Pack (3 ovule inserts) containing miconazole nitrate, expanding the p…
-
FDA approval · 2020-06-22FDA Approved: FLUCONAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for fluconazole submitted by Chartwell RX, LLC.
-
FDA approval · 2020-01-28FDA Approved: MONISTAT 3 COMBINATION PACK 3 OVULE INSERTS — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application for MONISTAT 3 Combination Pack 3 Ovule Inserts containing miconazole nitrate from Insight Pharm…
-
FDA approval · 2020-01-28FDA Approved: MONISTAT 7 7-DAY DISPOSABLE APPLICATORS — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application for MONISTAT 7 7-day disposable applicators containing miconazole nitrate, expanding the product…
-
FDA approval · 2020-01-28FDA Approved: MONISTAT 3 COMBINATION PACK — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application to authorize the MONISTAT 3 COMBINATION PACK containing miconazole nitrate from Insight Pharmace…
-
FDA approval · 2020-01-28FDA Approved: MONISTAT 1 COMBINATION PACK — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application for MONISTAT 1 COMBINATION PACK (miconazole nitrate) from Insight Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) [Phase 2]
Phase 2 study evaluating oral VT-1161 for recurrent vulvovaginal candidiasis has completed with results posted.
-
FDA approval · 2019-07-16FDA Approved: FLUCONAZOLE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Fluconazole from Zydus Lifesciences Limited, resulting in regulatory approval of this generic pr…
-
CLINICAL_TRIALS trial_result · 2019-07-12Clinical Trial Update: Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis [Phase 2]
Phase 2 trial comparing oral ibrexafungerp (SCY-078) to oral fluconazole in vulvovaginal candidiasis completed.
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: ProF-001_Phase IIa [Phase 2, Phase 3]
Phase IIa/III clinical trial update for ProF-001 in vulvovaginal candidiasis completed.
-
CLINICAL_TRIALS withdrawal · 2019-03-08Clinical Trial Update: Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis [Phase 3]
A Phase 3 trial evaluating LactiSal 1% Gel, LactSal 50 mg, and Clotrimazole 100 mg Tablet for vulvovaginal candidiasis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: Patients With Vulvovaginal Candidiasis [Phase 1, Phase 2]
Clinical trial update for vulvovaginal candidiasis across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) [Phase 2]
Phase 2 trial evaluating the safety and efficacy of oral encochleated amphotericin B (CAMB/MAT2203) for vulvovaginal candidiasis completed w…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) [Phase 2]
Phase 2 trial evaluating the efficacy and safety of oteseconazole (VT-1161) for acute vulvovaginal candidiasis has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis [Phase 1, Phase 2]
Phase 1/2 clinical trials evaluated the safety, tolerability, immunogenicity, and preliminary efficacy of the NDV-3A vaccine to prevent recu…
-
CLINICAL_TRIALS research · 2018-06-13Clinical Trial Update: Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis [NA]
A clinical trial evaluating the effect of Saccharomyces cerevisiae on vulvovaginal candidiasis has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: TOL-463 Phase 2 Study for Vaginitis [Phase 2]
The Phase 2 study of TOL-463 for vaginitis, covering bacterial vaginosis and vulvovaginal candidiasis, has completed.
-
CLINICAL_TRIALS research · 2018-03-02Clinical Trial Update: Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
Cidara Therapeutics (a Merck subsidiary) conducted a non-interventional extension to study recurrence of vulvovaginal candidiasis and Candid…
-
CLINICAL_TRIALS research · 2016-12-05Clinical Trial Update: Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis [NA]
A clinical trial evaluating the effect of Saccharomyces cerevisiae as an adjunct to standard therapy for vulvovaginal candidiasis was termin…